Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
The new factories will be built in the United States over the next five years and will create 3,000 jobs for qualified workers.
Eli Lily plans to spend at least $ 27 billion on the construction of four new manufacturing companies in the United States, said the drug manufacturer was facing the threat of drug import duties from the Trump administration.
The new factories will be built over the next five years and are expected to create more than 3,000 jobs for qualified workers such as engineers and scientists, as well as 10,000 workplaces, the company said at a press conference in Washington on Wednesday.
Lily said she would announce the sites on the sites later this year.
The announcement comes less than a week after US President Donald Trump met with chief leaders from major drug producers, including Lily David Ricks Executive Director, to discuss concerns in industry such as drug import tariffs.
US sales secretary Howard Luni told a press conference that Lily was doing “exactly what the president hoped to happen.”
Ricks said he hoped the government would release medical supplies from potential tariffs and continue to pursue more tax reforms.
The CEO said in a statement earlier on Wednesday that the tax reduction legislation introduced in Trump's first term is fundamental to the internal investment of the drug manufacturer.
Strengthening domestic production
Trump, which is a campaign with a promise to increase home production, accumulates pressure on drug manufacturers after taking office to move medicine production to the United States. He suggested last week that he could impose a 25 percent duty on pharmaceuticals and other imports.
Other sectors also make production messages. Earlier this week, Apple said it would spend $ 500 billion In the United States over the next four years, but analysts have said some of this include current commitments.
The US and its main trading partners have agreed to remove the reciprocal tariff for pharmaceuticals and chemicals used in the production of medicines over the last 30 years, according to the office of the US sales representative.
Although he told the Republicans at a White House meeting earlier this month that he was considering such a release, Trump is still not excluding them.
As a question about the dismissal of federal employees at the US Food and Drug Administration, the CEO said that Lily's fees are going to fund staff at the agency and the company will be concerned if these funds are “aimed at something else.”
Lilly, which has become the world's most valuable health company worth over $ 855 billion, said it has already made $ 23 billion to raise its $ 2020 production print in Wednesday has led to over $ 50 billion.
Three of Lily's new plants will be used to produce pharmaceutical raw ingredients, while the fourth will make injection medicines, the medicine said.
